Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease

Pamela J. Yao, Paul Coleman

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Abnormal protein processing and modification is associated with Alzheimer's disease (AD) pathology. The role of phosphorylation in AD has been studied extensively because the presumed abnormal phosphorylation of tau protein is believed to play a role in the formation of paired helical filaments. Glycosylation with O-linked N-acetylglucosamine (O-GlcNAc) to serine and threonine residues is a dynamic protein modification of intracellular proteins, and it shares similar features with protein phosphorylation. In this study, O-GlcNAc glycosylation of proteins from autopsied human brains with confirmed AD and non-AD age-matched controls was examined. O-GlcNAcylation was demonstrated by labeling protein extracts with [3H]galactose in the presence of galactosyltransferase and subsequent analyses of saccharide-protein linkage and saccharide structure. The number of O-GlcNAc-containing proteins and the overall O-GlcNAc level do not appear to be different between AD and control brain tissues. The only significant change observed is a marked reduction of O-GlcNAcylated clathrin assembly protein-3 (AP-3) in AD. The reduction is more evident in brain neocortical regions, and there appears to be a negative correlation between O- glycosylated AP-3 and the density of neurofibriliary tangles. These data suggest a possible association between the O-glycosylated AP-3 and AD pathology.

Original languageEnglish (US)
Pages (from-to)2399-2411
Number of pages13
JournalJournal of Neuroscience
Volume18
Issue number7
StatePublished - Apr 1 1998
Externally publishedYes

Fingerprint

Acetylglucosamine
Proteins
Alzheimer Disease
Phosphorylation
Glycosylation
Brain
Vesicular Transport Adaptor Proteins
Pathology
Galactosyltransferases
Alzheimer disease, familial, type 3
tau Proteins
Threonine
Galactose
Serine

Keywords

  • Alzheimer's disease
  • Clathrin assembly protein AP-3
  • Galatosyltransferase labeling
  • N-acetylglucosamine
  • Neurofibrillary tangles
  • O-linked glycosylation
  • Phosphorylation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease. / Yao, Pamela J.; Coleman, Paul.

In: Journal of Neuroscience, Vol. 18, No. 7, 01.04.1998, p. 2399-2411.

Research output: Contribution to journalArticle

@article{67f40d0980ce48b0bc0cac5fbfb70d61,
title = "Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease",
abstract = "Abnormal protein processing and modification is associated with Alzheimer's disease (AD) pathology. The role of phosphorylation in AD has been studied extensively because the presumed abnormal phosphorylation of tau protein is believed to play a role in the formation of paired helical filaments. Glycosylation with O-linked N-acetylglucosamine (O-GlcNAc) to serine and threonine residues is a dynamic protein modification of intracellular proteins, and it shares similar features with protein phosphorylation. In this study, O-GlcNAc glycosylation of proteins from autopsied human brains with confirmed AD and non-AD age-matched controls was examined. O-GlcNAcylation was demonstrated by labeling protein extracts with [3H]galactose in the presence of galactosyltransferase and subsequent analyses of saccharide-protein linkage and saccharide structure. The number of O-GlcNAc-containing proteins and the overall O-GlcNAc level do not appear to be different between AD and control brain tissues. The only significant change observed is a marked reduction of O-GlcNAcylated clathrin assembly protein-3 (AP-3) in AD. The reduction is more evident in brain neocortical regions, and there appears to be a negative correlation between O- glycosylated AP-3 and the density of neurofibriliary tangles. These data suggest a possible association between the O-glycosylated AP-3 and AD pathology.",
keywords = "Alzheimer's disease, Clathrin assembly protein AP-3, Galatosyltransferase labeling, N-acetylglucosamine, Neurofibrillary tangles, O-linked glycosylation, Phosphorylation",
author = "Yao, {Pamela J.} and Paul Coleman",
year = "1998",
month = "4",
day = "1",
language = "English (US)",
volume = "18",
pages = "2399--2411",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "7",

}

TY - JOUR

T1 - Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease

AU - Yao, Pamela J.

AU - Coleman, Paul

PY - 1998/4/1

Y1 - 1998/4/1

N2 - Abnormal protein processing and modification is associated with Alzheimer's disease (AD) pathology. The role of phosphorylation in AD has been studied extensively because the presumed abnormal phosphorylation of tau protein is believed to play a role in the formation of paired helical filaments. Glycosylation with O-linked N-acetylglucosamine (O-GlcNAc) to serine and threonine residues is a dynamic protein modification of intracellular proteins, and it shares similar features with protein phosphorylation. In this study, O-GlcNAc glycosylation of proteins from autopsied human brains with confirmed AD and non-AD age-matched controls was examined. O-GlcNAcylation was demonstrated by labeling protein extracts with [3H]galactose in the presence of galactosyltransferase and subsequent analyses of saccharide-protein linkage and saccharide structure. The number of O-GlcNAc-containing proteins and the overall O-GlcNAc level do not appear to be different between AD and control brain tissues. The only significant change observed is a marked reduction of O-GlcNAcylated clathrin assembly protein-3 (AP-3) in AD. The reduction is more evident in brain neocortical regions, and there appears to be a negative correlation between O- glycosylated AP-3 and the density of neurofibriliary tangles. These data suggest a possible association between the O-glycosylated AP-3 and AD pathology.

AB - Abnormal protein processing and modification is associated with Alzheimer's disease (AD) pathology. The role of phosphorylation in AD has been studied extensively because the presumed abnormal phosphorylation of tau protein is believed to play a role in the formation of paired helical filaments. Glycosylation with O-linked N-acetylglucosamine (O-GlcNAc) to serine and threonine residues is a dynamic protein modification of intracellular proteins, and it shares similar features with protein phosphorylation. In this study, O-GlcNAc glycosylation of proteins from autopsied human brains with confirmed AD and non-AD age-matched controls was examined. O-GlcNAcylation was demonstrated by labeling protein extracts with [3H]galactose in the presence of galactosyltransferase and subsequent analyses of saccharide-protein linkage and saccharide structure. The number of O-GlcNAc-containing proteins and the overall O-GlcNAc level do not appear to be different between AD and control brain tissues. The only significant change observed is a marked reduction of O-GlcNAcylated clathrin assembly protein-3 (AP-3) in AD. The reduction is more evident in brain neocortical regions, and there appears to be a negative correlation between O- glycosylated AP-3 and the density of neurofibriliary tangles. These data suggest a possible association between the O-glycosylated AP-3 and AD pathology.

KW - Alzheimer's disease

KW - Clathrin assembly protein AP-3

KW - Galatosyltransferase labeling

KW - N-acetylglucosamine

KW - Neurofibrillary tangles

KW - O-linked glycosylation

KW - Phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=0032053969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032053969&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 2399

EP - 2411

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 7

ER -